Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as liposomal SN-38, work in different ways to
stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing.
PURPOSE: This phase II trial is studying how well liposomal SN-38 works in treating patients
with small cell lung cancer.